glp 1 functional medicine GLP-1 Agonist Medications, Like Ozempic, for Weight Loss: A Health Coach's Take GLP-1 Medications for Weight Loss

Tan, R., Wang, Y., & Zhang, W

Top Research Studies on GLP-1s and Cardiovascular Outcomes The November 2023 issue of The New England Journal of Medicine shared results from a research study (SELECT) involving 17,000 patients that showed the use of semaglutide was linked to a 20% reduction in the risk of major adverse cardiovascular events such as heart disease, stroke and peripheral arterial disease in patients who had previously been diagnosed with heart disease

BMI cutoffs were built largely on data from White populations, and body fat distribution differs across ethnic groups

Our findings could pave the way for a novel preventive strategy against IBD and provide a safe and efficacious therapeutic approach for UC

The American Diabetes Association recommends an A1C goal of less than 7% for most adults